Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-04-003330
Filing Date
2004-06-14
Accepted
2004-06-14 14:44:18
Documents
5
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d59904_10-k.txt 10-K 188376
3 CONSENT OF ERNST & YOUNG LLP. d59904_ex23-1.txt EX-23.1 731
4 NOTICE RE CONSENT OF ARTHUR ANDERSEN LLP d59904_ex23-2.txt EX-23.2 3334
5 RULE 13A-14(A)/15D-14(A) CERTIFICATION d59904_ex31-1.txt EX-31.1 3479
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d59904_ex32-1.txt EX-32.1 1608
  Complete submission text file 0001169232-04-003330.txt   199643
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-14656 | Film No.: 04861109
SIC: 2836 Biological Products, (No Diagnostic Substances)